[{"arm_notes": "", "treatment_id": null, "treatment_name": "PFE-BNT was prepared under the recommendation of department of disease control; Thailand. Sterile 0.9% of Nacl 1.8 ml is added into PFE-BNT vaccine vial as a diluent. After diluting; each vial contains 6 doses of vaccine; each IM injection has 0.3 ml (30ug/dose). To prepare ID administration; the 1/5 dose of vaccine which is 0.06 ml (6ug/dose) was withdrawn from the vial using low dead-space (LDS) technique and syringe insulin ultrafine II. Vaccine was used within 3-4 hours after preparation. The intradermal administration technique was used during injection. The injection site is at the upper arm.;Experimental Drug;PFE-BNT Indradermal injection", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "1;ID;have previously completed 2 doses of a three-week schedule of Verocell", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]